PFE January 2028 Options Begin Trading

The article outlines specific options strategies for Pfizer (PFE) stock, detailing potential returns and probabilities for institutional investors. Selling a cash-secured put at the $18.00 strike, 25% out-of-the-money, could yield a 6.33% return (2.69% annualized) with a 74% chance of expiring worthless. Alternatively, a covered call strategy using the $25.00 strike, 4% out-of-the-money, offers a potential 13.02% total return if assigned by January 2028, or an 8.68% return (3.69% annualized) if it expires worthless, with a 54% probability. These strategies highlight opportunities for income generation or discounted stock acquisition, with implied volatilities of 36% for the put and 26% for the call, contrasting with PFE's 12-month historical volatility of 25%.

Analysis

The analysis focuses on two specific long-dated options strategies for Pfizer (PFE), utilizing January 2028 expirations to either generate income or acquire shares at a discount. The first strategy involves selling a cash-secured put at an $18.00 strike, representing a 25% discount to the current $23.96 share price. This strategy offers an effective entry point of $16.86 per share if assigned, or a 6.33% return on cash collateral (2.69% annualized) if the option expires worthless, an event with a 74% calculated probability. The second strategy is a covered call at a $25.00 strike, which could yield a 13.02% total return if the stock is called away, or an 8.68% yield enhancement (3.69% annualized) if it expires worthless, with a 54% probability. A key insight is the discrepancy in volatility pricing: the put's implied volatility is 36%, significantly higher than the stock's 25% trailing twelve-month actual volatility, while the call's implied volatility of 26% is closely aligned with the historical figure. This suggests that put options are relatively expensive, potentially reflecting higher perceived downside risk and making the put-selling strategy comparatively more attractive from a premium collection standpoint.

Key Decisions for Investors

• Investors bullish on PFE's long-term prospects but seeking a lower entry point should consider selling the January 2028 $18.00 put, which either secures shares at an effective cost basis of $16.86 or generates a 6.33% return on collateral.
• Current PFE shareholders aiming for income generation and willing to cap upside potential could implement the covered call strategy at the $25.00 strike to target a 13.02% total return if called away or an annualized 3.69% yield boost if not.
• Note the elevated implied volatility of 36% on the put option versus the 25% historical volatility, which indicates that selling puts may offer a superior risk-adjusted premium compared to selling calls at this time.
• Given the long-dated nature of these January 2028 options, investors must be prepared to commit capital or their stock position for a multi-year period, accepting the associated opportunity cost and long-term company risk.